Brennen Baylor focuses his practice on intellectual property matters in the life sciences industry. He prosecutes patent applications related to small molecules, pharmaceutical macromolecules, medical devices, agricultural chemistry, nutraceuticals, synthesis and use of nucleic acids and polypeptides, cell culturing systems and apparatuses, methods of culturing cells and methods of preparing tissue grafts. Brennen also has experience advising clients on inventions in the fields of chemical engineering systems, lithium batteries, manufacturing flooring composites, 3D printer filament compositions, and cellulose-based packaging materials.
Brennen develops go-to-market strategies for clients by providing detailed opinions on clients’ freedom to operate and the patentability of inventions. He assesses potential infringement by competitors and the validity of competitors’ intellectual property in anticipation of and preparation for litigation. Brennen also advises clients on comprehensive defense strategies in ongoing infringement litigation by providing invalidity and non-infringement analyses in coordination with co-counsel and expert witnesses.
In addition, Brennen assists clients by conducting due diligence on extensive pharmaceutical patent and trademark portfolios in connection with clients’ acquisition of competitors. He identifies risks associated with IP to be acquired and counsels clients on patent portfolio management strategy leading up to and following merger and restructuring.
While in law school, Brennen was a member of the Woolsack Honor Society, a Moot Court Board Senior Advocate and recipient of the CALI Excellence for the Future Award in Copyrights. Following law school and while practicing as a junior associate, Brennen earned his master’s degree in Biotechnology from Johns Hopkins University.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.